Fibromyalgia decisions — 2025

The Board remands the claims for further evidentiary development, including obtaining additional medical opinions to address the etiology of the Veteran's claimed conditions.

The Board granted an earlier effective date of June 25, 2013, for the grant of service connection for posttraumatic stress disorder (PTSD) and fibromyalgia.

The Board granted an earlier effective date of March 1, 2022, for the award of service connection for fibromyalgia.

The Board remands the matter to correct duty to assist errors, specifically requesting additional private medical records and an addendum medical opinion.

The Board denied the veteran's claim for service connection for fibromyalgia as there was no evidence of a current diagnosis of fibromyalgia at any time during the appeal period.

The appeal concerning the propriety of the rating reductions for the Veteran's right distal fibula disability and tinea pedis was dismissed, while SMC based on the need for aid and attendance was granted prior to February 20, 2024.

The Board remands the claims for service connection for fibromyalgia, chronic fatigue syndrome (CFS), bilateral upper extremity peripheral neuropathy, and bilateral lower extremity peripheral neuropathy as further development is needed.

The Board denied service connection for multiple conditions, including right hip disorder, genitourinary disorders, loss of sense of smell, and others, finding no evidence linking these conditions to the Veteran's military service or toxic exposure at Camp Lejeune.

The Board remands the claims for anemia, joint disability, and anal cancer to obtain additional evidence.

The Board remanded the claims for service connection for fibromyalgia and obstructive sleep apnea (OSA) due to incomplete evaluations. The claim for gastroesophageal reflux disease (GERD) was granted.

The Board denied the veteran's claims for an earlier effective date, a higher rating for chronic fatigue syndrome prior to December 27, 2022, and a compensable evaluation for hypertension.

The Board granted eligibility for the direct payment of attorney fees based on past due benefits awarded in an August 2022 rating decision granting entitlement to Special Monthly Compensation (SMC).

The Board denied service connection for fibromyalgia, a disability rating higher than 0 percent for photophobia with dry eye syndrome, and an initial disability rating higher than 0 percent for right knee scars. The claims for increased ratings were denied due to the Veteran's failure to appear for scheduled VA examinations.

The Board denied service connection for chronic fatigue and fibromyalgia, finding no current diagnosis separate from the Veteran's already service-connected conditions.

Service connection for rhinitis and GERD was granted, but denied for chronic fatigue syndrome and fibromyalgia.

The Board denied the veteran's appeal for a rating in excess of 60 percent for chronic fatigue syndrome (CFS). The veteran's symptoms were found to be severe but not warranting a higher rating.

The Board denied service connection for fibromyalgia because the evidence did not show a current diagnosis of this condition.

Service connection for fibromyalgia is granted. An increased disability rating of 70 percent for unspecified trauma and stressor related disorder with unspecified bipolar disorder is also granted. However, an effective date earlier than October 2, 2023, for eligibility to Dependents' Educational Assistance is denied.

The veteran's claim for an earlier effective date for CFS service connection was denied. The claim for gulf war syndrome/joint pain was remanded for further review due to new evidence.

The Veteran's claims for service connection for a back disability and fibromyalgia were dismissed because the Veteran did not file a timely appeal.